An inspiring hypoxia experiment

Written byBrendan Maher

| 1 min read

Jane Tomlinson, who is living with advanced breast cancer, starts her grueling 4200 mile, US-spanning bike ride to raise money for cancer research this Friday in San Francisco. According to her linkurl:Website,;http://www.janesappeal.com/ she?s run three London marathons, the NYC marathon, and completed the Ironman triathalon among other extreme exercise fundraisers since she was told nearly six years ago that she had six months to live. She?s been quoted as saying that she expects this to be the most difficult trek of her life. I bet she?ll recall that prediction climbing above the 10,000-foot mark in the Rockies. In many linkurl:tumor microenvironments,;http://www.the-scientist.com/article/display/23272/ a hypoxic state or genetic changes may trigger activity of the hypoxia inducible factor linkurl:(HIF),;http://www.the-scientist.com/article/display/13717 a transcription factor that turns on a slew of genes for angiogenesis and may linkurl:turn off DNA repair.;http://www.the-scientist.com/article/display/22629/ The tumor essentially fools the body into thinking it needs more oxygen at the site of the tumor. But as often seems the case with cancer, the same signal often has opposite effects. While her journey linkurl:into thin air;http://www.the-scientist.com/article/display/13207/ would likely trigger HIF, hypoxic conditions and hyperthermia have been linked to tumor death. Tomlinson?s truly a unique individual, of course. I?m amazed that someone undergoing chemo can find the energy she has, and she serves as an inspiration. (I couldn?t help but donate a little for a fellow biker.) I wonder, however, what kind of effects extreme exercise in hypoxic conditions have on tumor growth.

An inspiring hypoxia experiment

The Scientist ARCHIVES

Become a Member of

Related Topics

Meet the Author

Brendan Maher

Related Research Resources

A Stubborn Gene, a Failed Experiment, and a New Path

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Advancing Drug Discovery with Complex Human In Vitro Models

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Maximizing Cancer Research Model Systems

Products

Product News

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies